Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 11/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 11/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 10/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 10/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 10/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 8/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 9/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 5/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | GABRE | P78334 | 1/20 | 0.34 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.34 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.34 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20661071 | 0.81 | CYP11B1 (0.36) | ALDH1A1 | |
| SCHEMBL24253370 | 0.81 | CTSS (0.32) | NR3C2CTSSCTSK | |
| SCHEMBL16711506 | 0.76 | XPO1 (0.42) | ALDH1A1CTSSCTSKJAK2JAK1 | |
| SCHEMBL20660724 | 0.76 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL20660804 | 0.75 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL22290404 | 0.74 | GABRG2 (0.34) | GABRG2GABRB3GABRA5GABRA1GABRA2 | |
| SCHEMBL20671171 | 0.74 | BAZ2B (0.35) | ALDH1A1 | |
| SCHEMBL22980562 | 0.72 | GABRG2 (0.34) | GABRG2GABRB3GABRA5GABRA1GABRA2 | |
| SCHEMBL20660934 | 0.71 | KDM4E (0.37) | — | |
| SCHEMBL27028504 | 0.70 | GAA (0.45) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250080-A1 | ENZYME INHIBITORS | KALVISTA PHARMACEUTICALS LTD (GB) | 2023-08-10 | — | — | US | disclosed |
| EP-4010333-A1 | PLASMA KALLIKREIN INHIBITORS | Kalvista Pharmaceuticals Limited (GB) | 2022-06-15 | — | — | EP | disclosed |
| WO-2021028645-A1 | PLASMA KALLIKREIN INHIBITORS | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021028645-A1 | PLASMA KALLIKREIN INHIBITORS | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021028649-A1 | PLASMA KALLIKREIN INHIBITORS | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021028649-A1 | PLASMA KALLIKREIN INHIBITORS | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2021-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250080-A1 | ENZYME INHIBITORS | SERPINB1, KLKB1, SERPINE1 | GABRG2 3222/4885GABRB3 3086/4885GABRA5 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.